These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 24803024)

  • 1. Enhanced anti-cancer efficacy to cancer cells by doxorubicin loaded water-soluble amino acid-modified β-cyclodextrin platinum complexes.
    Zhao MX; Zhao M; Zeng EZ; Li Y; Li JM; Cao Q; Tan CP; Ji LN; Mao ZW
    J Inorg Biochem; 2014 Aug; 137():31-9. PubMed ID: 24803024
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The delivery of doxorubicin of multifunctional β-cyclodextrin-modified CdSe/ZnS quantum dots for bioactivity and nano-probing.
    Zhao MX; Zhu BJ; Yao WJ; Chen DF; Wang C
    Chem Biol Drug Des; 2018 Jan; 91(1):285-293. PubMed ID: 28791767
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Polymersomes via Self-Assembly of Amphiphilic β-Cyclodextrin-Centered Triarm Star Polymers for Enhanced Oral Bioavailability of Water-Soluble Chemotherapeutics.
    Hu M; Shen Y; Zhang L; Qiu L
    Biomacromolecules; 2016 Mar; 17(3):1026-39. PubMed ID: 26840277
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Folate-modified poly(2-ethyl-2-oxazoline) as hydrophilic corona in polymeric micelles for enhanced intracellular doxorubicin delivery.
    Qiu LY; Yan L; Zhang L; Jin YM; Zhao QH
    Int J Pharm; 2013 Nov; 456(2):315-24. PubMed ID: 24016742
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Substituted beta-cyclodextrin and calix[4]arene as encapsulatory vehicles for platinum(II)-based DNA intercalators.
    Krause-Heuer AM; Wheate NJ; Tilby MJ; Pearson DG; Ottley CJ; Aldrich-Wright JR
    Inorg Chem; 2008 Aug; 47(15):6880-8. PubMed ID: 18597414
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Functionalized
    Kang EJ; Baek YM; Hahm E; Lee SH; Pham XH; Noh MS; Kim DE; Jun BH
    Int J Mol Sci; 2019 Jan; 20(2):. PubMed ID: 30646562
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Glutamine-β-cyclodextrin for targeted doxorubicin delivery to triple-negative breast cancer tumors via the transporter ASCT2.
    Zhou P; Liang X; Zhou C; Qin J; Hou C; Zhu Z; Zhang W; Wang S; Zhong D
    J Mater Chem B; 2019 Sep; 7(35):5363-5375. PubMed ID: 31403158
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Study of glycol chitosan-carboxymethyl β-cyclodextrins as anticancer drugs carrier.
    Tan H; Qin F; Chen D; Han S; Lu W; Yao X
    Carbohydr Polym; 2013 Apr; 93(2):679-85. PubMed ID: 23499111
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synthesis and biological evaluation of novel folic acid receptor-targeted, β-cyclodextrin-based drug complexes for cancer treatment.
    Yin JJ; Sharma S; Shumyak SP; Wang ZX; Zhou ZW; Zhang Y; Guo P; Li CZ; Kanwar JR; Yang T; Mohapatra SS; Liu W; Duan W; Wang JC; Li Q; Zhang X; Tan J; Jia L; Liang J; Wei MQ; Li X; Zhou SF
    PLoS One; 2013; 8(5):e62289. PubMed ID: 23658721
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A novel lactoferrin-modified β-cyclodextrin nanocarrier for brain-targeting drug delivery.
    Ye Y; Sun Y; Zhao H; Lan M; Gao F; Song C; Lou K; Li H; Wang W
    Int J Pharm; 2013 Dec; 458(1):110-7. PubMed ID: 24126038
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Delivery of hydrophilic drug doxorubicin hydrochloride-targeted liver using apoAI as carrier.
    Yuan Y; Wang W; Wang B; Zhu H; Zhang B; Feng M
    J Drug Target; 2013 May; 21(4):367-74. PubMed ID: 23600747
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intracellular redox-activated anticancer drug delivery by functionalized hollow mesoporous silica nanoreservoirs with tumor specificity.
    Luo Z; Hu Y; Cai K; Ding X; Zhang Q; Li M; Ma X; Zhang B; Zeng Y; Li P; Li J; Liu J; Zhao Y
    Biomaterials; 2014 Sep; 35(27):7951-62. PubMed ID: 24930850
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Active Drug Targeting of a Folate-Based Cyclodextrin-Doxorubicin Conjugate and the Cytotoxic Effect on Drug-Resistant Mammary Tumor Cells In Vitro.
    Mizusako H; Tagami T; Hattori K; Ozeki T
    J Pharm Sci; 2015 Sep; 104(9):2934-40. PubMed ID: 25940848
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Doxorubicin-loaded amphiphilic polypeptide-based nanoparticles as an efficient drug delivery system for cancer therapy.
    Lv S; Li M; Tang Z; Song W; Sun H; Liu H; Chen X
    Acta Biomater; 2013 Dec; 9(12):9330-42. PubMed ID: 23958784
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cyclodextrin derivatives conjugated with aromatic moieties as pH-responsive drug carriers for anthracycline.
    Swiech O; Dutkiewicz P; Wójciuk K; Chmurski K; Kruszewski M; Bilewicz R
    J Phys Chem B; 2013 Oct; 117(43):13444-50. PubMed ID: 24079546
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vitro demonstration of enhanced prostate cancer toxicity: pretargeting with Bombesin bispecific complexes and targeting with polymer-drug-conjugates.
    Patil V; Gada K; Panwar R; Majewski S; Tekabe Y; Varvarigou A; Khaw BA
    J Drug Target; 2013 Dec; 21(10):1012-21. PubMed ID: 23863118
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A liposome preparation based on β-CD-LPC molecule and its application as drug-delivery system.
    Cai A; Wang C; Yan M; Ma L; Liu W; Li F; Liu T; Song P; Gao Z; Li J; Xin M; Wei G
    Nanomedicine (Lond); 2018 Nov; 13(21):2777-2789. PubMed ID: 30247090
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hydroxypropyl-β-cyclodextrin copolymers and their nanoparticles as doxorubicin delivery system.
    Wang T; Zhang C; Liang XJ; Liang W; Wu Y
    J Pharm Sci; 2011 Mar; 100(3):1067-79. PubMed ID: 20922814
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Citric acid-γ-cyclodextrin crosslinked oligomers as carriers for doxorubicin delivery.
    Anand R; Malanga M; Manet I; Manoli F; Tuza K; Aykaç A; Ladavière C; Fenyvesi E; Vargas-Berenguel A; Gref R; Monti S
    Photochem Photobiol Sci; 2013 Oct; 12(10):1841-54. PubMed ID: 23900688
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Folate-appended β-cyclodextrin as a promising tumor targeting carrier for antitumor drugs in vitro and in vivo.
    Okamatsu A; Motoyama K; Onodera R; Higashi T; Koshigoe T; Shimada Y; Hattori K; Takeuchi T; Arima H
    Bioconjug Chem; 2013 Apr; 24(4):724-33. PubMed ID: 23458386
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.